or
forgot password
  • cancer clinical trials in little rock, AR

  • Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Neuroblastoma
    Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

    Little Rock, Arkansas 72205-7199
    Breast Neoplasm
    A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
    University of Arkansas for Medical Sciences, Arkansas Cancer Research Center
    Little Rock, Arkansas
    Acute Myelogenous Leukemia
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Colorectal Cancer
    Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma, Non-Hodgkin, Multiple Myeloma
    A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Oral Mucositis, Stomatitis
    ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

    Little Rock, Arkansas 72205-7199
    Ovarian Neoplasms
    Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
    ImClone Investigational Site
    Little Rock, Arkansas 72205
    Metastatic Pancreatic Cancer
    Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients
    Investigational Site 025
    Little Rock, Arkansas 72206
    Multiple Myeloma
    S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Gastric Cancer
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Head and Neck Cancer
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Hematology Oncology Services of Arkansas
    Ovarian Neoplasms
    Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Neoplasms, Prostate, Prostate Cancer
    Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Small Cell Lung Cancer
    Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Human Papillomavirus Type-16/-18 Infection, Papillomavirus Vaccines, Cervical Neoplasia
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
    Hematology Oncology Services of Arkansas
    Little Rock, Arkansas 72205
    Neuroendocrine Carcinoma
    Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    TroVax Renal Immunotherapy Survival Trial
    Little Rock Hematology / Oncology Associates, P.A.
    Little Rock, Arkansas 72205
    Clear Cell Renal Carcinoma
    Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
    Little Rock Hematology Oncology
    Little Rock, Arkansas 72205
    Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    University of Arkansas Myeloma Institute
    Little Rock, Arkansas 72205
    Cytomegalovirus Infections
    A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

    Little Rock, Arkansas 72205-7199
    Lymphoma, Non-Hodgkin, Multiple Myeloma, Giant Lymph Node Hyperplasia
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Mary K. Richards, Md Pa
    Little Rock, Arkansas 72204
    Atrial Fibrillation, Atrial Flutter
    Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
    Arkansas Cancer Research Center
    Little Rock, Arkansas 72205
    Multiple Myeloma
    The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Nausea and Vomiting, Chemotherapy-Induced, Cancer
    Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    Little Rock Dermatology Clinic
    Little Rock, Arkansas 72205
    Psoriasis
    Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
    Arkansas Children's Hospital

    Trial Locations
    Arkansas Children's Hospital
    Little Rock Allergy & Asthma Clinic
    Hereditary Angioedema
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
    University of Arkansas
    Little Rock, Arkansas 72202
    Uterine Cancer, Endometrial Cancer
    Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Relapsed Breast Cancer, Neoplasms, Breast
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    Winthrop P. Rockefeller Cancer Institute
    Little Rock, Arkansas 72205
    Melanoma
    Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Non-small Cell Lung Cancer
    Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Non-small Cell Lung Cancer
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Little Rock Hematology Oncology Associates
    Little Rock, Arkansas 72205
    Small Cell Lung Cancer
    Study With Candida Antigen for Treatment of Warts
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Warts, HPV
    UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    MULTIPLE MYELOMA
    Treatment of Oral Premalignant Lesions With 5-ALA PDT
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukoplakia, Erythroplakia
    Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adrenal Insufficiency
    Effects of Exercise in Combination With Epoetin Alfa
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    UARK 2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Head and Neck Cancer
    Human Cord Blood Transplantation in Advanced Hematological Malignancies
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Head and Neck Cancer Screening and Serum Repository
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Head and Neck Squamous Cell Cancer
    A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Nausea and Vomiting, Nausea and Vomiting, Chemotherapy-Induced
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 155

    Trial Locations
    BioSante Site 155
    BioSante Site #060
    Hypoactive Sexual Desire Disorder
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 9705
    Little Rock, Arkansas 72211
    Prostate Cancer
    Preemptive Strike With Bortezomib in Multiple Myeloma Patients
    University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma
    Hematology Oncology Services of Arkansas
    Little Rock, Arkansas 72205
    Neuroendocrine Carcinoma
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer
    Hematology Oncology Services of Arkansas
    Little Rock, Arkansas 72205
    Breast Cancer
    Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Recurrent Small-cell Lung Cancer (SCLC), Lung Cancer, Small Cell
    Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

    Little Rock, Arkansas 72205-7199
    Rheumatoid Arthritis
    Percutaneous Excision Trial
    University of Arkansas for Medical Services
    Little Rock, Arkansas 72205
    Imaged Breast Abnormalities
    Safety and Efficacy Study of Switching From Epzicom to Truvada
    Health For Life Clinic, PLLC
    Little Rock, Arkansas 72207
    HIV Infection
    Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
    Lynn Institute of the Ozarks
    Little Rock, Arkansas 72205
    Uterine Fibroids